期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (1)
Objectives Rezafungin EUCAST MIC testing has been associated with notable inter-laboratory variation, which prevented ECOFF setting for C. albicans. W......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (1)
Objective To estimate the effect of treatment duration on in-hospital mortality in patients with Staphylococcus aureus blood stream infection and demo......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (2)
This study evaluates the impact of the presence of antiretroviral resistance mutations in an HIV-infected paediatric cohort in Panama from 2019-2020. ......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (5)
Background While the treatment of ESBL-producing Enterobacterales osteomyelitis relies on carbapenems, the optimal regimen for OXA48 types remains unc......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (5)
Objectives To develop a transferable process, CATALYST (challenging antibiotic allergy status), to assess and challenge penicillin allergy status of i......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (6)
Objectives There is clinical uncertainty over the optimal treatment for penicillin-susceptible Staphylococcus aureus (PSSA) infections. Furthermore, t......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 ()
Background Streptococcus pneumoniae continues to be an important bacterial pathogen associated with invasive (e.g. bacteraemia, meningitis) and non-in......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (12)
Objectives Low- and middle-income countries (LMICs) are particularly vulnerable to the threat of antimicrobial resistance (AMR). Use of antibiotics to......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (1)
Objectives Actinomycetoma is a chronic granulomatous disease affecting skin, subcutaneous tissue, fascia, muscle and bones. With increasing resistance......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (4)
Background Cloxacillin is the first-line treatment for methicillin-susceptible staphylococcal infective endocarditis (IE). The recommended dose is 12 ......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (4)
As one of a series of thematically linked reviews of the primary pharmacology of the beta-lactam/beta-lactamase inhibitor combination, ceftazidime/avi......
期刊： JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023; 78 (6)
Objectives: The subcutaneous (SC) route provides an alternative to the IV or oral route for drug administration in the elderly. The benefits of SC adm......
